Back to Agenda
Keynote Address 1
Session Chair(s)
Yoshinobu Hirayama, PHD
Professor, College of Pharmaceutical Sciences, Ritsumeikan University, Japan
iPS cells have dramatically shortened the distance from research to patients, and made it possible for patients to get involved in medicinal development. Research has been conducted to establish iPS cells from patients with various genetic diseases, promote scientific analysis of pathological disease conditions with known genetic etiology at the cell level, and determine a variety of factors which affect pathological conditions by analyzing somatic cells from patients with unknown genetic etiology. In addition, iPS cells are used to verify the safety of medicine as well as search for candidates for new medicine. Furthermore, they enable cell transplant therapy by combination with gene therapy. In this session, Dr. Nakahata will introduce the current situation and future possibilities of new medicine development brought by iPS cells.
Speaker(s)
Tatsutoshi Nakahata, MD, PHD
Deputy Director and Professor, Center for iPS Cell Research and Application (CiRA), Kyoto University, Japan
Recent Progress in iPS Cell Research and Application
Have an account?